QC Bioassay / Incoming & Components Analyst
📍 Location: Merseyside
📅 Contract: 6 Months
🏢 Company: Global Biopharmaceutical Organisation
Overview
We are supporting a global biopharmaceutical organisation based in Liverpool in the search for an experienced QC Analyst to join their Quality Control team on a 6-month contract.
This role will focus on the compliant execution of QC testing, inspection, and release activities across both bioassay and incoming materials/components, supporting critical vaccine manufacturing operations.
You will also contribute to technical and validation studies, ensuring alignment with both departmental and site objectives.
Key Responsibilities
QC Bioassay
* Perform QC testing on in-process, intermediate, and finished vaccine products
* Conduct data review and interpretation in line with approved SOPs
* Ensure all work is carried out in compliance with cGMP and regulatory standards
* Accurately document all laboratory activities, ensuring data integrity
* Support method validation, transfer, and technical studies
QC Incoming & Components
* Perform primary QC inspection and sampling of raw materials
* Conduct testing of primary and secondary packaging components
* Review and interpret analytical data in accordance with SOPs
* Support the release of raw materials and components for manufacturing
* Assist in deviations, investigations, and CAPA activities
Requirements
* Fluent in English (written and verbal)
* Proven experience in QC testing techniques relevant to the role (bioassay and/or raw materials/components testing)
* Strong experience working within a cGMP-regulated environment
* Clear understanding of GMP compliance, documentation, and data integrity principles
* Awareness of equipment qualification and method validation requirements
* Understanding of root cause analysis and its application within investigations
* Strong IT skills with experience using electronic laboratory and quality systems (e.g. LIMS, electronic documentation systems)
* Demonstrable experience working within the pharmaceutical or biopharmaceutical industry under cGMP conditions